In collaboration with Deloitte, we launched in 2020 the DayOne Health Data Scenario Project. Some 50 Experts coming together in three workshops for a total of more than 18 hours have identified 10 potential scenarios that will lead the way in creating a much-needed efficient and rewarding healthcare data ecosystem. We presented our results in an online joint event: “Understanding the health data future – Deloitte Healthconnect, co-hosted by DayOne”
“It’s cheaper to clean up a mess than to avoid a mess.” This mantra, coined by Alan Greenspan explaining why financial bubbles happen, stands very much at the core of how we as a society typically seem to deal with health: rather than nudging and rewarding people to conduct a healthier life and increase their immunity, the primary focus of efforts and resources is often on treating sickness.
How can this change? What role do health data, nutrition and immunity play in this? And what difference would it make? Find out at our next DayOne Experts Event, co-hosted by DSM Nutritional Products.
There are a couple of reasons why it is not an easy thing to successfully implement preventive measures. First of all, behavioral change is hard to accomplish. Secondly, in most cases it is challenging to show the scientific evidence that a certain measure works and is worth the effort. One key focus area is the importance of an optimal nutrient intake to support our health – with a focus on immunity and beyond. Last but not least, we need to consider a business and policy model that makes prevention less of a moral burden but a worthwhile experience that we are willing to apply in a smart way.
These are the big questions we will address at the DayOne Experts Event:
Will the rise of digital and data availability change the landscape – and if so to what extent?
What can we learn from the current pandemic?
Does nutrition play a role in supporting your immunity?
Which data should we take into consideration to shape the future?
This was our conversation. Read the conclusions here: https://www.dayone.swiss/as-shown-by-covid-19-making-prevention-smart-requires-a-mind-shift/
Our partner: DSM Nutritional Products
Value-based Healthcare - Towards a systems approach in chronic diseasesnDayOne
Role of patient journey in science, predictive modeling and high-risk patients in early stages of disease progression, in real world context. Presented by Michael Rebhan, Novartis at the DayOne Basel event in June 2020
For the 5th year, we culminated the best of the DayOne Healthcare Innovation initiative: hot topics, open debates, smart insights, bright ideas, high energy personalities and tangible expertise. This will include the Open Innovation Session that brings together the Health Hack and is a springboard for the Accelerator. The panel sessions included: The patient centric approach + four bright ideas; How to make it happen; + The healthcare innovation journey.
This year’s conference joined forces with BioData Congress 2020 in a virtual format. Thank you to the partners Arcondis and Innosuisse, as well as all the mentors, coaches and behind the scenes work to pull this all together in a great event wtih over 800 participants.
openimis data privacy consultation with DayOneDayOne
The Swiss TPH and DayOne held a consultation around how to develop appropriate data privacy guidelines in Jan 2019. These are the slides as presented and notes from the event.
Pioneering value & data driven healthcare for PatientsDayOne
Presentation by Michel Mohler (Lyfegen) at the DayOne Expert Event Legal challenges and opportunities for digital health innovation.
it is essential to address the legal aspects early on and make them part of the solution. This was shown by this start-up showcase:
It’s an expensive und exhausting run against time: It takes approximately 2,3 billion Dollars and 12 years to bring a drug to the market. This leaves only 8 years until the expiration of the patent to bring back sufficient return on investments. So far, this has worked out well for the industry but the run is getting steeper every year: on the one hand, it becomes increasingly complex and expensive to develop new drugs, on the other hand prizes are under scrutiny. Hence, the industry is sitting on a time bomb, as the day will come when the returns will not cover the investments anymore and the innovation pipeline will dry out because bringing new drugs to the market does no longer offer any financial incentives.
What can be done about this scenario? Eventually (and hopefully), these projections prove wrong as there is still a lot to be gained by efficiency improvement through digitalizing all along the value chain – after all healthcare still is one of the least digitalized industries. Will this be enough – or do we have to reinvent healthcare innovation in a radical new way?
This DayOne Experts Event showcased some game changing ideas and discussed their feasibility and impact with an expert panel and the audience. These slides are just the intro to this Event.
Background on the 30 projects pitching at the DayOne Conference on 9th September 2019. At the conference the projects will be assisted by mentors and conference participants to create a journey map to help them on their path to healthcare innovation.
Powering the Future of Healthcare in Asia - ETPL "IOT FOR HEALTH" PROGRAM | T...Julien de Salaberry
Presentation on the importance and impact of IoT Healthcare / Healthtech on the delivery of healthcare in Asia to the ETPL "IOT FOR HEALTH" PROGRAM cohort
#healthtechasia
“It’s cheaper to clean up a mess than to avoid a mess.” This mantra, coined by Alan Greenspan explaining why financial bubbles happen, stands very much at the core of how we as a society typically seem to deal with health: rather than nudging and rewarding people to conduct a healthier life and increase their immunity, the primary focus of efforts and resources is often on treating sickness.
How can this change? What role do health data, nutrition and immunity play in this? And what difference would it make? Find out at our next DayOne Experts Event, co-hosted by DSM Nutritional Products.
There are a couple of reasons why it is not an easy thing to successfully implement preventive measures. First of all, behavioral change is hard to accomplish. Secondly, in most cases it is challenging to show the scientific evidence that a certain measure works and is worth the effort. One key focus area is the importance of an optimal nutrient intake to support our health – with a focus on immunity and beyond. Last but not least, we need to consider a business and policy model that makes prevention less of a moral burden but a worthwhile experience that we are willing to apply in a smart way.
These are the big questions we will address at the DayOne Experts Event:
Will the rise of digital and data availability change the landscape – and if so to what extent?
What can we learn from the current pandemic?
Does nutrition play a role in supporting your immunity?
Which data should we take into consideration to shape the future?
This was our conversation. Read the conclusions here: https://www.dayone.swiss/as-shown-by-covid-19-making-prevention-smart-requires-a-mind-shift/
Our partner: DSM Nutritional Products
Value-based Healthcare - Towards a systems approach in chronic diseasesnDayOne
Role of patient journey in science, predictive modeling and high-risk patients in early stages of disease progression, in real world context. Presented by Michael Rebhan, Novartis at the DayOne Basel event in June 2020
For the 5th year, we culminated the best of the DayOne Healthcare Innovation initiative: hot topics, open debates, smart insights, bright ideas, high energy personalities and tangible expertise. This will include the Open Innovation Session that brings together the Health Hack and is a springboard for the Accelerator. The panel sessions included: The patient centric approach + four bright ideas; How to make it happen; + The healthcare innovation journey.
This year’s conference joined forces with BioData Congress 2020 in a virtual format. Thank you to the partners Arcondis and Innosuisse, as well as all the mentors, coaches and behind the scenes work to pull this all together in a great event wtih over 800 participants.
openimis data privacy consultation with DayOneDayOne
The Swiss TPH and DayOne held a consultation around how to develop appropriate data privacy guidelines in Jan 2019. These are the slides as presented and notes from the event.
Pioneering value & data driven healthcare for PatientsDayOne
Presentation by Michel Mohler (Lyfegen) at the DayOne Expert Event Legal challenges and opportunities for digital health innovation.
it is essential to address the legal aspects early on and make them part of the solution. This was shown by this start-up showcase:
It’s an expensive und exhausting run against time: It takes approximately 2,3 billion Dollars and 12 years to bring a drug to the market. This leaves only 8 years until the expiration of the patent to bring back sufficient return on investments. So far, this has worked out well for the industry but the run is getting steeper every year: on the one hand, it becomes increasingly complex and expensive to develop new drugs, on the other hand prizes are under scrutiny. Hence, the industry is sitting on a time bomb, as the day will come when the returns will not cover the investments anymore and the innovation pipeline will dry out because bringing new drugs to the market does no longer offer any financial incentives.
What can be done about this scenario? Eventually (and hopefully), these projections prove wrong as there is still a lot to be gained by efficiency improvement through digitalizing all along the value chain – after all healthcare still is one of the least digitalized industries. Will this be enough – or do we have to reinvent healthcare innovation in a radical new way?
This DayOne Experts Event showcased some game changing ideas and discussed their feasibility and impact with an expert panel and the audience. These slides are just the intro to this Event.
Background on the 30 projects pitching at the DayOne Conference on 9th September 2019. At the conference the projects will be assisted by mentors and conference participants to create a journey map to help them on their path to healthcare innovation.
Powering the Future of Healthcare in Asia - ETPL "IOT FOR HEALTH" PROGRAM | T...Julien de Salaberry
Presentation on the importance and impact of IoT Healthcare / Healthtech on the delivery of healthcare in Asia to the ETPL "IOT FOR HEALTH" PROGRAM cohort
#healthtechasia
Presentation given at the Garage Start Digital Health Startup Workshop sponsored by ABRT Venture Capital. Content focuses on the healthtech investment landscape.
The FDA Digital Health Center of Excellence and the Advancement of Digital He...Greenlight Guru
The FDA Digital Health Center of Excellence is part of the planned evolution of the digital health program with the intent to drive synergy for digital health efforts, align strategy with implementation, prepare the FDA for the digital health future, and protect patients and maintain the FDA standards of safety and effectiveness.
Ultimately, the program works to strategically advance science and evidence for digital health technologies that meets the needs of
stakeholders.
This free in-depth webinar, presented by Matthew DiamondChief Medical Officer, Digital Health Center of Excellence, will cover the digital health landscape and areas of application, goals and outcomes, planned services and launch plan, and the current areas of focus - including AI/ML-Based SaMD.
This presentation originally aired during the 2021 State of Medical Device Virtual Summit.
Top 10 fastest growing healthcare tech companies 2021insightscare
Top 10 Fastest-Growing Healthcare TechCompanies, 2021 brings to your desk a listing of innovative companies striving to design & deliver cutting-edge products & solutions.
The healthcare industry is being disrupted by technology and a shift to greater patient / individual empowerment. This represents a formidable opportunity for healthcare in Asia. What catalyst role could / should strategics play in Asia healthcare innovation and how?
I manage my health with digital tools and I’m not alone. An estimated and growing 69% of consumers and patients are also engaged in monitoring their own healthcare . The interest in personal wellness combined with the proliferation of healthcare ‘wearables’ available to consumer puts us on the cusp of an extraordinary shift in healthcare: Technology enabled patients are empowered to change their lifestyle to prevent or stop chronic disease, and become healthier than ever before. The implications of this on every aspect of the healthcare industry –from delivery and population health to access and cost will be astounding.
But wearable technology is still in its infancy, quite complex and limited in what it can do. The next generation will be intelligent and voice-enabled and go beyond tracking to interacting with and assisting consumers with their healthcare choices, and changing behaviors for the better. Imagine a wearable that could warn you of risks developing, nudge you towards better choices for that day based on your health profile, and keep you engaged in a treatment regime.
Trends in Digital Health and why you should careMichael Weber
Driven by demographic change, rising costs in the healthcare system and growing customer demands for patient-centered tools, the relevance of innovative Digital Health solutions is constantly growing. While many technologies are available on the market, there is still a lack of comprehensive solutions that support the patient across all his medical conditions and provide an integrated user experience throughout the patient's everyday life. Future Digital Health solutions will not only have to cross-link patient data across different devices and applications in order to enable better medical decisions, but also to create user experiences that address the patients' needs and help them to establish self-sustaining behaviors towards a healthier lifestyle.
Healthcare, along with many other sectors, is facing increasing uncertainty driven by technology disruption and greater individual / patient empowerment. The barrier to entry into the sector is dropping fast enabling Asia entrepreneurs to significantly improve the Asia healthcare ecosystem
Gartner ranked Dell the #1 worldwide IT services provider in healthcare in 2014. Dell sees global disruptions in healthcare delivery and continues to invest in strategies to address these rapid changes. They are actively enhancing development, implementation and adoption of novel technologies, services, and applications that will revolutionize information-driven care, resulting in improved patient outcomes and overall cost savings worldwide. Dr. Nick is responsible for providing strategic insight and will discuss some Dell’s strategies to achieve an IT environment that is interconnected, efficient and patient-focused.
Powering the Future of Healthcare in Asia Pacific | Full ReportGalen Growth
How technology will change healthcare delivery
1) The creative destruction of healthcare
2) Data driven healthcare
3) Funding
4) Disruption in Healthcare
5) Opportunity to leapfrog to accelerate change
By: Karsten Russell-Wood, Philips Hospital to Home
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
At Modern Health Talk, we see the future of mHealth as less about Mobile health and more about MODERN healthcare that includes all sorts of solutions for addressing demographic shift of retiring baby boomers and the resulting doctor shortage.
These solutions include mobile technologies (smartphones & tablets) and big broadband support of high-def video calls with medical imaging, as well as new delivery options such as retail clinics and insurance-funded home care (and home modifications), remote sensor monitoring, healthcare robots, Watson-like cloud services, new laws & regulations, support of family caregivers, and more.
Vator Splash Health, Wellness & Wearables 2017
A presentation on the Vator conference in San Francisco, CA. Perhaps one of my favorite conference series in health tech featuring many perspectives: tech, insurance, genomics, behavioral health, diagnostics, devices and more.
AcuMedical was formed with the purpose of designing, developing, and promoting a minimally-invasive, integrated suite of medical devices that help patients and healthcare professionals effectively manage a variety of chronic or acute pain conditions through electro-stimulation.
It is crucial to highlight the atrocities occurring within the pain management industry. More specifically, prescription opioid-based painkillers, whose crippling side effects have now led to the White House declaring an official “public health emergency” in the United States. The rise of opioids to the forefront of the healthcare system has not only led to exponentially increasing overdose and hospitalization cases but also encourages illegal drug distribution to a growing population of victims.
Electro-stimulation and needle therapy procedures are well-known for their safety and effectiveness in treating chronic and acute pain. They are recommended by the FDA as a non-pharma therapy and useful in opiate rehab. AcuMedical has developed patent-pending technologies that introduce a procedure-based, digital electro-needle therapy platform that collects data qualified toward reliable insurance reimbursement and streamlines the therapy making patient treatment safer, consistent, and more effective.
With the global market for pain management devices totaling more than $3.2Bn in 2016 within the growing $60Bn global pain management therapeutics market, our products are positioned to gain prominence and compete within the exponentially expanding $130Bn traditional Chinese medicine market in China post-internationalization.
Navigating Age-Tech, e-health enablers for home & community care. Dr. Martin Chasen, Medical Director Supportive Palliative Care Program at William Osler Health System, and Nectari Charitakis CEO & Co-founder of uCarenet share three digital health solutions to enable seniors and patients to receive the care they need at home. Helping them to stay out of hospital or institutional care environments.
Presentation given at the Garage Start Digital Health Startup Workshop sponsored by ABRT Venture Capital. Content focuses on the healthtech investment landscape.
The FDA Digital Health Center of Excellence and the Advancement of Digital He...Greenlight Guru
The FDA Digital Health Center of Excellence is part of the planned evolution of the digital health program with the intent to drive synergy for digital health efforts, align strategy with implementation, prepare the FDA for the digital health future, and protect patients and maintain the FDA standards of safety and effectiveness.
Ultimately, the program works to strategically advance science and evidence for digital health technologies that meets the needs of
stakeholders.
This free in-depth webinar, presented by Matthew DiamondChief Medical Officer, Digital Health Center of Excellence, will cover the digital health landscape and areas of application, goals and outcomes, planned services and launch plan, and the current areas of focus - including AI/ML-Based SaMD.
This presentation originally aired during the 2021 State of Medical Device Virtual Summit.
Top 10 fastest growing healthcare tech companies 2021insightscare
Top 10 Fastest-Growing Healthcare TechCompanies, 2021 brings to your desk a listing of innovative companies striving to design & deliver cutting-edge products & solutions.
The healthcare industry is being disrupted by technology and a shift to greater patient / individual empowerment. This represents a formidable opportunity for healthcare in Asia. What catalyst role could / should strategics play in Asia healthcare innovation and how?
I manage my health with digital tools and I’m not alone. An estimated and growing 69% of consumers and patients are also engaged in monitoring their own healthcare . The interest in personal wellness combined with the proliferation of healthcare ‘wearables’ available to consumer puts us on the cusp of an extraordinary shift in healthcare: Technology enabled patients are empowered to change their lifestyle to prevent or stop chronic disease, and become healthier than ever before. The implications of this on every aspect of the healthcare industry –from delivery and population health to access and cost will be astounding.
But wearable technology is still in its infancy, quite complex and limited in what it can do. The next generation will be intelligent and voice-enabled and go beyond tracking to interacting with and assisting consumers with their healthcare choices, and changing behaviors for the better. Imagine a wearable that could warn you of risks developing, nudge you towards better choices for that day based on your health profile, and keep you engaged in a treatment regime.
Trends in Digital Health and why you should careMichael Weber
Driven by demographic change, rising costs in the healthcare system and growing customer demands for patient-centered tools, the relevance of innovative Digital Health solutions is constantly growing. While many technologies are available on the market, there is still a lack of comprehensive solutions that support the patient across all his medical conditions and provide an integrated user experience throughout the patient's everyday life. Future Digital Health solutions will not only have to cross-link patient data across different devices and applications in order to enable better medical decisions, but also to create user experiences that address the patients' needs and help them to establish self-sustaining behaviors towards a healthier lifestyle.
Healthcare, along with many other sectors, is facing increasing uncertainty driven by technology disruption and greater individual / patient empowerment. The barrier to entry into the sector is dropping fast enabling Asia entrepreneurs to significantly improve the Asia healthcare ecosystem
Gartner ranked Dell the #1 worldwide IT services provider in healthcare in 2014. Dell sees global disruptions in healthcare delivery and continues to invest in strategies to address these rapid changes. They are actively enhancing development, implementation and adoption of novel technologies, services, and applications that will revolutionize information-driven care, resulting in improved patient outcomes and overall cost savings worldwide. Dr. Nick is responsible for providing strategic insight and will discuss some Dell’s strategies to achieve an IT environment that is interconnected, efficient and patient-focused.
Powering the Future of Healthcare in Asia Pacific | Full ReportGalen Growth
How technology will change healthcare delivery
1) The creative destruction of healthcare
2) Data driven healthcare
3) Funding
4) Disruption in Healthcare
5) Opportunity to leapfrog to accelerate change
By: Karsten Russell-Wood, Philips Hospital to Home
At Sherbrooke International Life Sciences Summit - 2nd edition | September 28/29/30 2015
www.sils-sherbrooke.com
At Modern Health Talk, we see the future of mHealth as less about Mobile health and more about MODERN healthcare that includes all sorts of solutions for addressing demographic shift of retiring baby boomers and the resulting doctor shortage.
These solutions include mobile technologies (smartphones & tablets) and big broadband support of high-def video calls with medical imaging, as well as new delivery options such as retail clinics and insurance-funded home care (and home modifications), remote sensor monitoring, healthcare robots, Watson-like cloud services, new laws & regulations, support of family caregivers, and more.
Vator Splash Health, Wellness & Wearables 2017
A presentation on the Vator conference in San Francisco, CA. Perhaps one of my favorite conference series in health tech featuring many perspectives: tech, insurance, genomics, behavioral health, diagnostics, devices and more.
AcuMedical was formed with the purpose of designing, developing, and promoting a minimally-invasive, integrated suite of medical devices that help patients and healthcare professionals effectively manage a variety of chronic or acute pain conditions through electro-stimulation.
It is crucial to highlight the atrocities occurring within the pain management industry. More specifically, prescription opioid-based painkillers, whose crippling side effects have now led to the White House declaring an official “public health emergency” in the United States. The rise of opioids to the forefront of the healthcare system has not only led to exponentially increasing overdose and hospitalization cases but also encourages illegal drug distribution to a growing population of victims.
Electro-stimulation and needle therapy procedures are well-known for their safety and effectiveness in treating chronic and acute pain. They are recommended by the FDA as a non-pharma therapy and useful in opiate rehab. AcuMedical has developed patent-pending technologies that introduce a procedure-based, digital electro-needle therapy platform that collects data qualified toward reliable insurance reimbursement and streamlines the therapy making patient treatment safer, consistent, and more effective.
With the global market for pain management devices totaling more than $3.2Bn in 2016 within the growing $60Bn global pain management therapeutics market, our products are positioned to gain prominence and compete within the exponentially expanding $130Bn traditional Chinese medicine market in China post-internationalization.
Navigating Age-Tech, e-health enablers for home & community care. Dr. Martin Chasen, Medical Director Supportive Palliative Care Program at William Osler Health System, and Nectari Charitakis CEO & Co-founder of uCarenet share three digital health solutions to enable seniors and patients to receive the care they need at home. Helping them to stay out of hospital or institutional care environments.
The ten predictions for 2020
1. Health consumers in 2020
Informed and demanding patients are now partners in their own healthcare
2. Health care delivery systems in 2020
The era of digitised medicine - new business models drive new ideas
3. Wearables and mHealth applications in 2020
Measuring quality of life not just clinical indicators
4. Big Data in 2020
Health data is pervasive – requiring new tools and provider models
5. Regulation in 2020
Regulations reflect the convergence of technology and science
6. Research and Development in 2020
The networked laboratory - partnerships and big data amidst new scrutiny
7. The pharmaceutical commercial model in 2020
Local is important but with a shift from volume to value
8. The pharmaceutical enterprise configuration - the back office in 2020
Single, global and responsible for insight enablement
9. New business models in emerging markets in 2020
Still emerging, but full of creativity for the world
10. Impact of behaviours on corporate reputation in 2020
A new dawn of trust
IoMT: The Start of a New Era in the Healthcare IndustryPixel Crayons
Read the full blog here: https://bit.ly/32Mo5kx
Connect with us through:
Contact us : https://bit.ly/2IpPX7w
Facebook : https://www.facebook.com/PixelCrayons
Twitter : https://twitter.com/pixelcrayons
LinkedIn : https://www.linkedin.com/company/pixelcrayons
Instagram : https://www.instagram.com/pixelcrayons/
Pinterest : https://in.pinterest.com/pixelcrayons/
2B Kalfhaus Opportunities and Challenges of Telemedicine EHiN 2014IKT-Norge
Lars Kalfhaus
Country Manager Roche Diabetes Care (ES)
Connect, Engage and Take Decisions
Opportunities and Challenges of Telemedicine Implementation
EHiN 2014, IKT-Norge og HOD
Webinar: Digital Health Strategy: Leveraging Emerging Technologies in HealthcareIntellectsoft
WEBINAR VIDEO - https://www.intellectsoft.net/l/31/webinar-digital-healthcare
JOIN OUR WEBINAR TO:
- Explore what changed for healthcare practices and operations during COVID-19 and predict what leaders can expect in terms of recovery;
- Discover today’s featured examples of our clients’ technology solutions that can help you provide better and more efficient services;
- Discuss how to evolve and adapt for the rest of 2020 and into 2021 using emerging technologies and more efficient solutions.
BEST FOR:
- Сhief Medical Officers
- Doctors Pharmaceuticals
- HR Department Outstaffing
- Telemedicine Workers
- Insurance Companies
- Pharmacies
- Laboratories
- Private Hospitals
- Academical Health Centres
- Private Healthcare Facilities
- Management Information Systems
https://www.intellectsoft.net/
Abstract:
Currently, there is a convergence of three key factors in the global landscape that creates an opportunity for the research community to make fundamental contributions to improving the quality of life of every single citizen. Conversely, failure to recognize and act on this phenomenon may have disastrous effects on multiple levels. The first factor is the unprecedented focus and willingness to invest in the healthcare industry. The second factor is the fact that the prime directive of the healthcare sector, i.e. nothing interferes with the delivery of care, has ramifications on every aspect of information technology used in this domain. The final factor is the recognition that patient empowerment and buy-in will be critical for the advance of health information technology. These factors highlight the fact that there are inherent assumptions in the existing access models that render them ineffective and not applicable for long term use in the healthcare field.
This talk will highlight all these issues and challenge the research community to delve more the industry-specific constraints that require further innovation in the space; possibly necessitating a re-examination of the core assumptions in the field.
Bio:
Tyrone Grandison is currently the Program Manager for Core Healthcare Services in the Healthcare Transformation group of the IBM Services Research organization (Hawthorne, New York). His immediate interests are in developing innovative solutions for ensuring patient privacy protection and for integrating information from multiple sources to get more complete views of patients to enable better decision making. Prior to this, Tyrone led the Intelligent Information Systems (Quest) team in the Computer Science department at the IBM Almaden Research Center (San Jose, California). The team pioneered research in Relational Database Privacy, Disclosure-Compliant Query Processing for RFID and Mobile Data Networks, Security Exception Handling in Healthcare Information Systems and Large Scale Text Analysis of Online Data. Tyrone is a Distinguished Engineer of the Association of Computing Machinery (ACM), Senior Member of the Institute of Electrical and Electronics Engineers (IEEE) and has been further recognized by the IEEE (2010 Technical Achievement Award), the National Society of Black Engineers (i.e. Pioneer of the Year 2009) and the Black Engineer of the Year Award Board (i.e. Modern Day Technology Leader 2009, Minority in Science Trailblazer 2010). Tyrone received his B.Sc. and M.Sc. degrees from the University of the West Indies, Jamaica in 1997 and 1998, respectively, and a Ph.D. degree from the Imperial College of Science, Technology and Medicine in the United Kingdom.
Presented: June 9, 2010
The 2023 Digital Health Barometer_compressed.pdfJordiCarreras13
Data interoperability requires the adoption and
implementation of common and (ideally) open
standards. Lack of interoperability limits the
re-use of data between healthcare organisations
within a country and across borders. The rise of
cloud platforms and mobile technology further
complicates the data environment. “Data gets
captured and it is quite complex and hard to
share,” says David Hansen, CEO of the Australian
e-Health Research Centre, CSIRO. “When shared,
it is often not computable. Human intervention
is needed to do analytics and this is really
expensive.”
All countries except Spain achieve the highest
score on this indicator, demonstrating that
digital health and health information industrybased
technical standards for data exchange,
transmission, messaging, security, privacy and
hardware are in use in the majority of applications
and systems to ensure the availability of highquality
data.
Digital health literacy and internet connectivity
are ‘super’ social determinants of health, as
they have the power to affect the wider social
determinants of health.17 Although the use of
digital tools – such as apps, patient portals, and
monitoring devices – provides better support
beyond clinical settings, greater reliance on them
can increase the disparity between people with
digital access and skills and those without, and (by
extension) health disparities.18 “One of the major
concerns globally in digital health has been tech
equity,” says Majmudar. “The digital divide could
worsen. You need access to the internet, tools
and resources. Every country should focus on
connectivity, including the US. Can people afford
the data plans they need to access telemedicine
and remote care? Do we have connectivity in
every area, urban or rural?”
7 Reasons why Companies & Government should invest in Digital TransformationIsmail Sayeed
Early adoption of digital solutions to provide services, whether health related or not, allows organisations to be ready for future user demands. The large pool of data on patterns of service/product consumption, feedback and possible future behaviour (extracted from data analytics) can guide strategic decisions on what to invest in and for whom.
Digital healthcare innovation was needed decades ago, with or without a global health emergency. Other industries with complex systems have rapidly adopted digital transformation; such as logistics networks, taxation, commerce and others
- except healthcare.
A company that is already accustomed to some form of digital-based communication and operations (as much as possible) are the ones most able to survive and thrive in these circumstances.
A government body that can still function and serve remotely and digitally is the most ideal form of democracy. An organisation with remote workers, paperless reporting, established telecommunications through all chains of command are really agile in its truest form.
I had predicted 2 years ago that digital healthcare solutions would be the dominant narrative for the emerging middle class of many developing countries in Asia.
it is time for the global industry to transform itself to the new reality.
Now.
How life sciences can win with blockchainToni Borges
The IBM Institute for Business Value surveyed 205 life sciences executives in 18 countries. The study, conducted in collaboration with the Economist Intelligence Unit (EIU), included chief financial officers (CFOs), chief technology officers (CTOs) and chief information officers (CIOs). Those participating had to meet specific criteria: they were either working with — or planning to work with — blockchains in the next 12 months, and they needed to be familiar with the blockchain strategies of their organizations.
Big data: how it will help us?
The goal of this summit is to combine the different perspectives of data scientists, healthcare professionals, patients and governance to find the much- needed consensus for the next generation of healthcare systems. Join us and share your views and experience. The Health Data Forum online summit was held last 7 and 8 May as another living proof that Virtual doesn't mean Distant.
Similar to Understanding the health data future - Deloitte Healthconnect, co-hosted by DayOne (20)
Breathe - Empowering parents of children with asthmaDayOne
Presentation by Moritz Dietsche (Haako) at the DayOne Expert Event Legal challenges and opportunities for digital health innovation.
it is essential to address the legal aspects early on and make them part of the solution. This was shown by this start-up showcase:
Legal Framework for Digital Health Innovation - Data Protection and SecurityDayOne
Presentation by Monika Menz, Vossius & Partner at the DayOne Expert Event Legal challenges and opportunities for digital health innovation.
Data - GDPR still governs the data protection landscape and is here to stay. But GDPR is more than an implementation issue – innovators need to embrace its principles already when designing their products, not only to be compliant but also to gain the trust of customers and patients. As healthcare innovations are IT dependent and data driven, data and IT security are often neglected. But they are key to convincing investors and customers of the innovator’s business model, because the stakes are high, not only in terms of a start-up’s reputation and liability, but ultimately and most of all in terms of the patient’s interests as well.
EU regulatory frameworks - Legal challenges and opportunities for digital hea...DayOne
Presentation by Karin Schulze, Head of Medical Devices at SFL at the DayOne Expert Event Legal challenges and opportunities for digital health innovation
Regulation
Regarding the new MDR, the big question that arises is not only whether a piece of software falls under the definition of a medical device, but also who decides whether it does. At least in this regard the new regulation is clear: it is the regulator. Which means, according to Karin Shulze from SFL, that If a company offers an app which they do not consider a medical device themselves, but the regulator does, the distribution of this app will be stopped.
Legal framework for digital health innvoation - Protection through patents, d...DayOne
Presentation by Philipp Marchand and Birgitte Bieler, Vossius & Partner at the DayOne Expert Event Legal challenges and opportunities for digital health innovation
Philipp Marchand from Vossius & Partner and co-host of the event said: “Technological developments, especially in the digital space, brought up completely new issues which lack clear definition. So, as lawyers and regulatory advisers, we have to be innovative and also come up with new solutions. This is a learning curve we have to go through together with entrepreneurs, industry and regulatory bodies“.
In other words, instead of being a French garden à la Versaille, the legal landscape has become a rather rough terrain to navigate. The uncertainty can be seen as a threat and show killer. A more entrepreneurial attitude, however, would be to see it as an opportunity, if not an invitation, to pursue more of a greenfield approach. But in order to make this happen, it is essential to address the legal aspects early on and make them part of the solution.
Protection
Accustomaed as it is to a science and engineering-driven approach, the healthcare industry has to change its mindset when it comes to protecting its business. As it is reasonable to patent a digital solution and to protect medical devices as well as mobile app interfaces by means of design and trademark rights, the legal framework is becoming more important. So, developing a great technological solution and then having it beautified later on will not suffice. Those capabilities have to be built in from day one to ensure freedom to operate and to generate added value from the digital solutions.
Expert Event Legal challenges and opportunities for digital health innovationDayOne
Introduction by Thomas Brenzikofer, DayOne, Basel Area Business & Innovation
Greenfield or jungle? Navigating the legal landscape for digital healthcare innovation
At first sight, it’s hard not to agree that dealing with the legal aspects of creating healthcare innovation is — although necessary — a rather unsexy topic. So it comes as no surprise that the DayOne Experts Event “Legal challenges and opportunities for healthcare innovation”, held online on September 30, attracted a slightly smaller audience than when the talks usually concern revolutionary new pieces of digital technology ready to disrupt healthcare as we know it — for the better.
Future of aging day one 20200630 zaynakhayatDayOne
What comes to mind when you think of an older person? Who are they? Where do they live? What does their day look like? How do they want to live their life, make money, spend money, experience services and leave a legacy?
These are just some among the many provocative questions that were researched in the new book “The Future of Aging” by Zayna Khayat. The book provides a much needed «reboot» of the perspective on how society needs to engage with the aging population. It is also a reminder of the limits to current approaches to aging. The vision Zayna Khayat proposes is intended to help individuals and organizations of all types and from all sectors position themselves as long-term partners on whom aging adults can depend as they navigate their experiences of aging.
Innovation for the future of aging will include new policies, services, products, technologies, living spaces, and even approaches to shaping inter-generational communities—all of which will be transformative for the lives of older adults. The potential societal and economic returns from innovation for the future of aging are immense, and therefore need to be prioritized.
It’s time to redefine what it means to age.
We are proud to host Zayna Khayat for the DayOne LabTalk to discuss innovation opportunities for the future of aging!
This event is part of our Aging Well Catalyst project by DayOne: a journey which will seek out innovative solutions that can help with both functional and psycho-social well-being. Learn more at Dayone.swiss
Value-based Healthcare today and tomorrow by Deloitte.DayOne
There is an increasing need for a value-based Healthcare based on holistic patient and health system outcomes. Success can only be reached by a genuinely collaborative approach.
Presented at the DayOne Expert event in Basel
The slides in this deck are what were discussed in the first of five Aging Well workshops. This first workshop focused on mobility for aging adults. Take a look.
How can digital bridge the mental health gaps?
Mental health is a story of gaps. This was made clear by all the speakers and panelists at DayOne’s most recent Expert Meeting titled “Measuring the Unmeasurable - will digital pave the way for new treatments in mental health?” which took place in Basel. Check out the slides from the event here.
20191203 DOE Data Driven Healthcare- Expert EventDayOne
DayOne Experts - Data-driven healthcare – are we ready?
Data is transforming healthcare. Health data from multiple sources such as electronic health records, genomic testing, imaging and digital tools, combined with advanced analytics can be used to deliver more personalised care, improve outcomes, empower patients and make healthcare more sustainable and efficient. But is the industry ready for these new approaches? What is needed on the policy level and in the regulatory field to enable a new era of data driven health solutions? How will their business models look like?
This is what we discussed at this DayOne Expert Event, which was proudly presented in close collaboration with the Embassy of the Netherlands, fostering the exchange between two world leading healthcare innovation ecosystems.
Healthcare delivery in the periphery workshop outputDayOne
A tri-national (CH, D, F) group of healthcare and labor experts came together at the DayOne lab to brainstorm on common initiatives to tackle the challenges of Healthcare delivery in our region. Please find attached the output of our workshop here.
What does “patient centricity” really mean and how is it actually done? This was the driving question of the DayOne Experts Meeting in Basel, co-hosted by Arcondis.
Input speech to panel on ethics from Evelyne Bischof, Shanghai University of Medicine & Health Sciences University Hospital Basel at the DayOne Conference 2019 Shaping the future of Health September 9th 2019
Durrenmatt's Computer Scientists: Caught between moral and technological deve...DayOne
Input speech to panel on ethics from Bram Stieltjes, University Hospital Basel at the DayOne Conference 2019 Shaping the future of Health September 9th 2019
How start-up funding in digital health can workDayOne
Input speech to panel on future financing from Andreas Igel from Arcondis at the DayOne Conference 2019 Shaping the future of Health September 9th 2019
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Understanding the health data future - Deloitte Healthconnect, co-hosted by DayOne
1. Welcome to the
Deloitte HealthConnect –
The future of Health Data
webinar!
We are waiting for all the
participants to join and we will get
started shortly…
2. 2
Zoom guidance
How can you interact? Webinarsupport
EleonoraZelger
ZoomMaster
• If you have any technical difficulties or require assistance
with Zoom, please write to Eleonora Zelger in the chat box
and I will try to help you as soon as possible
Chatfor technical difficulties
On sound
• Everyone is on mute by default in the beginning of the
webinar and cannot unmute
Optimizingyourview
• To optimize your view, you can toggle between speakers and
slides by clicking on the button in the right top corner
Askquestions
• You can use the “Q&A” box to ask your questions during the
whole webinar
• Please note that you can submit the questions anonymously
4. The Future of Health Data
Today’s Panel
NicoKleyn
ManagingPartner for Life
Sciences and Healthcarefor
Switzerlandand North South
Europe, Deloitte
AntonioRusso
Innovation Leader and
Partner,Deloitte
NishantSinha
Life Sciences Director,
Deloitte
ThomasBrenzikofer
Co-Founder, DayOne
AlexanderFink
Member of Executive Board,
ScMI
KatrinCrameri
Director,SIB PersonalizedHealth
and InformaticsGroup & SPHN
Data CoordinationCentre
Egle Thomas
ManagingDirector of Stratergix
GmbH
MichaelRebhan
Senior PrincipalScientist,
Novartis
Randall McGuire
Managerof Economic Affairs,
Novartis
StefanoNapolitano
Managementand Platform
Business Developer, Midata
5. The Future of Health Data
Today’s Agenda
16:00-16:10CET Welcome • Nico Kleyn; Managing Partner for Life Sciences and Healthcarefor Switzerland and
North South Europe, Deloitte
16:10-16:25CET The HealthDataScenarios • ThomasBrenzikofer;Co-Founder,DayOne
16:25-16:40CET The HealthDataEcosystemof the future • Nishant Sinha; Director, Deloitte
16:40-17:20CET The Futureof HealthData • Michael Rebhan; Senior Principal Scientist, Novartis
Panel Discussion • Randall McGuire;Manager of Economic Affairs, Novartis
• Alexander Fink; Member of Executive Board, ScMI
• StefanoNapolitano; Managementand Platform Business Developer, Midata
• KatrinCrameri;Director, SIB Personalized Health and InformaticsGroup & SPHN Data
Coordination Centre
• EgleThomas; Swiss InnovationAgency
• AntonioRusso; Innovation Leaderand Partner, Deloitte
Facilitatedby: • ThomasBrenzikofer;Co-Founder,DayOne
17:20-17:30CET Wrapup andOutlook • ThomasBrenzikofer; Co-Founder,DayOne
8. Vision/purpose
Together with great innovators,
through collaboration and
partnerships, we continue to
build a strong ecosystem to
deliver solutions for better
health.
9. What we offer
A healthcare innovation platform with
a unique bundle of services that
reinforce each other to enable
transformation:
1. A community/network to
connect
2. Events to get inspired
3. Catalyst projects to activate
4. An accelerator program to grow
5. A hub for life sciences and
innovation to establish your
presence in Europe
6. Workspaces to collaborate
14. Wisdom of the Crowd
50+ experts
3 Sessions, 18+ hours of workshop
pulling together knowledge and insights
co-creating tangible outcome:
10 Scenarios